LifeMD Inc (LFMD)
7.77
+0.05
(+0.65%)
USD |
NASDAQ |
May 17, 16:00
7.92
+0.15
(+1.93%)
After-Hours: 20:00
LifeMD Cash from Investing (Quarterly): -2.190M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.190M |
December 31, 2023 | -2.217M |
September 30, 2023 | -2.404M |
June 30, 2023 | -2.301M |
March 31, 2023 | -1.812M |
December 31, 2022 | -1.771M |
September 30, 2022 | -2.242M |
June 30, 2022 | -2.515M |
March 31, 2022 | -7.378M |
December 31, 2021 | -1.578M |
September 30, 2021 | -0.8534M |
June 30, 2021 | -0.9216M |
March 31, 2021 | -0.0489M |
December 31, 2020 | -0.0675M |
September 30, 2020 | -0.0534M |
June 30, 2020 | -0.2088M |
March 31, 2020 | -0.4684M |
December 31, 2019 | 0.40M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -0.50M |
December 31, 2018 | -0.10M |
September 30, 2018 | -0.1486M |
Date | Value |
---|---|
June 30, 2018 | 0.20M |
March 31, 2018 | 0.19M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.10M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | -0.10M |
December 31, 2013 | |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-7.378M
Minimum
Mar 2022
0.40M
Maximum
Dec 2019
-1.432M
Average
-1.25M
Median
Cash from Investing (Quarterly) Benchmarks
Veradigm Inc | -9.254M |
TruBridge Inc | 16.39M |
Streamline Health Solutions Inc | -0.012M |
PetMed Express Inc | -1.423M |
LENZ Therapeutics Inc | 18.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 5.202M |
Cash from Financing (Quarterly) | -1.048M |
Free Cash Flow | 7.524M |
Free Cash Flow Per Share (Quarterly) | 0.0768 |
Free Cash Flow to Equity (Quarterly) | 3.123M |
Free Cash Flow Yield | 2.71% |